Are drug prices value-based?
One of the central tensions in pharmaceutical policy is the gap between what a drug…
Are drug prices value-based?
One of the central tensions in pharmaceutical policy is the gap between what a drug is worth and what it actually costs. In theory, a drug’s price should reflect its value — its ability to improve health outcomes relative to the next best alternative. In practice, list prices are set by manufacturers, net prices are shaped by opaque…
Come help save democracy!
Tuesday, May 5 | 8-9 pm ET, 5-6 pm PT Protecting Healthcare and Our Democracy: A conversation with Mandy Cohen, Former Director, Centers for Disease Control and Prevention PLUS former NC Governor Roy Cooper & Dr. Donald Berwick, IHI founder/former president REGISTER & DONATE A matching fund of $70,000 is in effect for this event! This…
Move Over Doximity — There’s a New Social Network for Doctors
Roon is a new physician-only social network. The platform — founded by a neurosurgeon and two former Pinterest executives — aims to surface the “collective wisdom” of doctors that currently lives in informal exchanges and fragmented online communities. The post Move Over Doximity — There’s a New Social Network for Doctors appeared first on MedCity…
Prevention Efforts Increasingly See Suicide Through a Broader Lens
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Someone in America dies by suicide every 11 minutes. It’s that common. But that doesn’t make it normal. Humans have evolved over centuries to survive. So when people try to kill themselves, something has gone wrong….
Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation
Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug for this indication, and Axsome’s pill has a safety advantage. The post Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation appeared first on MedCity News.
Why Clinical Digital Out-of-Home Displays Are Healthcare’s Most Untapped Advertising Opportunity
The inventory is already built. The audience is already there. The problem is what the channel can prove — and that problem is solvable. The post Why Clinical Digital Out-of-Home Displays Are Healthcare’s Most Untapped Advertising Opportunity appeared first on MedCity News.
The Multimodal Explosion: Why 2026 Breaks the AI Paradigm
Accuracy, completeness, and efficiency all matter when benchmarking a successful AI platform. But there’s another metric that’s often overlooked: the minutes of eye contact returned to the exam room. The post The Multimodal Explosion: Why 2026 Breaks the AI Paradigm appeared first on MedCity News.
Why Metabolic Health Is a Common Thread Across Diabetes, Heart Disease, and Some Cancer
A common mechanism for reversing metabolic disease in some patients seems to be the sustained flattening of the hills and valleys of glucose and insulin. The post Why Metabolic Health Is a Common Thread Across Diabetes, Heart Disease, and Some Cancer appeared first on MedCity News.
Recent Changes to Temporary Protected Status Designations: Potential Impacts on Health and Health Care
This brief provides an overview of the TPS program, recent changes to TPS designations announced by the Trump administration, and potential implications of loss of TPS for individuals on health and health care.
Changes to the Medicare Advantage Program Enhance Some Consumer Protections But Roll Back Others
CMS recently finalized policies as part of the 2027 Medicare Advantage final rule that both enhance consumer protections and roll back changes to the Medicare Advantage program that were intended to protect consumers. These changes have gotten less attention than payment issues and changes to the star ratings system, which also affect plan payments, but…
